# Comparative Effectiveness of INTERCEPT Fibrinogen Complex (IFC) and Cryoprecipitate-AHF (Cryo-AHF) for Treatment of Trauma Associated Hemorrhage

> **NCT07218185** · — · NOT_YET_RECRUITING · sponsor: **Cerus Corporation** · enrollment: 320 (estimated)

## Conditions studied

- Hypofibrinogenemia
- Hemorrhage

## Interventions

- **BIOLOGICAL:** Pathogen Reduced Cryoprecipitated Fibrinogen Complex
- **BIOLOGICAL:** Cryoprecipitated-Antihemophilic Factor

## Key facts

- **NCT ID:** NCT07218185
- **Lead sponsor:** Cerus Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2028-02
- **Final completion:** 2028-08
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2025-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07218185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07218185, "Comparative Effectiveness of INTERCEPT Fibrinogen Complex (IFC) and Cryoprecipitate-AHF (Cryo-AHF) for Treatment of Trauma Associated Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07218185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*